Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
about
Proteome analysis of schizophrenia patients Wernicke's area reveals an energy metabolism dysregulationProteomics Research in SchizophreniaA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesMass spectrometry for the detection of potential psychiatric biomarkersThe post-synaptic density of human postmortem brain tissues: an experimental study paradigm for neuropsychiatric illnessesAltered functional protein networks in the prefrontal cortex and amygdala of victims of suicideA method for improving SELDI-TOF mass spectrometry data quality.Evaluation of tissue collection for postmortem studies of bipolar disorderFrontal-subcortical protein expression following prenatal exposure to maternal inflammation.The role of proteomics in depression researchProteomic analysis of lymphoblastoid cells derived from monozygotic twins discordant for bipolar disorder: a preliminary study.Bipolar disorder: recent advances and future trends in bioanalytical developments for biomarker discovery.Extracellular matrix abnormalities in schizophreniaDissecting the Syndrome of Schizophrenia: Progress toward Clinically Useful Biomarkers.Recent advances in applying mass spectrometry and systems biology to determine brain dynamics.Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia.CNS proteomes in alcohol and drug abuse and dependence.Is brain banking of psychiatric cases valuable for neurobiological research?Alcoholism: protein expression profiles in a human hippocampal model.Target identification for CNS diseases by transcriptional profiling.Social stress in adolescents induces depression and brain-region-specific modulation of the transcription factor MAXProteomic research in psychiatry.Profiling for novel proteomics biomarkers in neurodevelopmental disorders.An integrative functional genomics approach for discovering biomarkers in schizophrenia.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biology.Effect of social interactions on hippocampal protein expression in animal dominant and submissive model of behavioral disorders.Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Anterior hippocampus in schizophrenia pathogenesis: molecular evidence from a proteome study.
P2860
Q21260256-11661740-488C-4B2A-8E83-03B4C5B00642Q26766821-A559BBB3-DA79-45C0-B3ED-2CC86540BC60Q26786354-30172952-C952-48A2-9325-F1EA291F1F57Q26852637-26E1CB54-C24D-4B8A-B216-550B72C5BEEDQ28475295-6F3F1625-C70E-4A6D-8BD6-BE4BC2184493Q28485508-7932184E-9B0F-4754-A0DE-263FAAC10F77Q31125985-9F63A0F1-2415-4886-8995-6B442310179BQ33762704-6B46FA57-DD00-4918-BBC8-E2AEF2BA2E03Q33828632-6A1D7DAF-60BC-456E-BFA1-D83723845695Q34130553-0F2DB8E1-7440-4AFE-95C9-19E776F9316AQ34585836-486201DA-9F3B-42EB-B718-5E89AE645E30Q35460424-3E3C1BE2-5623-4BAD-888D-CA6EAAF0DDEAQ35603175-1ECEA321-E92D-4D83-B193-9C7BCF8DE980Q36168593-FD76E3F6-D7A0-4F4E-A562-13ACD7DDD832Q36379339-261F91DB-D755-44BD-B7D8-3F4E6A248582Q36748153-59393F70-405A-47D5-BCE2-22696D9E02EDQ36913057-75FD7916-CDF2-45D0-9F83-9DC2DA60A894Q37147332-F75B00D0-E41A-406D-937B-37972B8605E9Q37157859-81A04D9D-8993-476A-B74F-CA6754116FE0Q37175279-5EFE0E75-D658-45C0-8449-C63B2407EEBEQ37650449-6884B3DD-AD7C-4B83-A163-917C49329552Q37689362-0FAD001D-6A15-41EF-B35F-DBCD10224D90Q37844157-9AF2925D-23D0-4B30-8A1A-9D95BE334847Q37966594-8F310373-40B6-4CA2-BB08-DC8F549B38BFQ38027217-E5A8CC11-35C0-4713-BEAE-ADFAF4864EEBQ38187682-61C0DA18-035D-47DA-BE56-F4716DC2C5F1Q38692694-318A8B1D-A7FD-47F5-AAAB-C65E592BF12BQ38939217-3EB03A28-770B-4792-989C-C04610B882DDQ40058836-515F513D-5AF5-488B-B8FE-4E8E2785577AQ48698691-3ED3A64A-EFAA-479B-B8FA-F62102F533DE
P2860
Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@ast
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@en
type
label
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@ast
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@en
prefLabel
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@ast
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@en
P2093
P921
P1476
Identification of protein biom ...... ith MALDI-TOF-PSD-MS analysis.
@en
P2093
Michael S Lidow
Nicholas J Cutrufello
Svetlana I Novikova
P356
10.1016/J.NBD.2006.02.002
P577
2006-03-20T00:00:00Z